Fredun Pharmaceuticals schedules 39th AGM for June 30, 2026

1 min read     Updated on 09 Jun 2026, 01:20 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Fredun Pharmaceuticals Limited has announced its 39th Annual General Meeting for June 30, 2026, to be held via video conference. The meeting will address the financial year 2025-26, with book closure from June 24 to June 30, 2026. Shareholders can participate through remote e-voting starting June 27, 2026.

powered bylight_fuzz_icon
41876003

*this image is generated using AI for illustrative purposes only.

Fredun Pharmaceuticals Limited has scheduled its 39th Annual General Meeting (AGM) for June 30, 2026, at 9:00 a.m. via video conference (VC) and other audio-visual means (OAVM). The meeting will cover the business of the financial year ending March 31, 2026. To determine shareholder eligibility, the Register of Members and Share Transfer Books will remain closed from June 24, 2026, to June 30, 2026.

The company has informed the exchange that letters are being dispatched to members whose email addresses are not registered with the company, its Registrar & Share Transfer Agent (Purva Shareregistry (India) Private Limited), or depository participants. These letters provide the exact web-link to access the Annual Report for FY 2025-26 and the Notice convening the 39th AGM.

Meeting and Book Closure Details

The schedule for the book closure and the AGM is outlined below:

Feature Details
Book Closure Start Date June 24, 2026
Book Closure End Date June 30, 2026
AGM Date June 30, 2026
AGM Time 9:00 a.m.
Mode Video Conference (VC) / Other Audio Visual Means (OAVM)
Financial Year FY 2025-26

The Annual Report is available on the company's website at http://www.fredungroup.com/investor-annual-report.html#investor . Shareholders holding securities in physical mode are reminded to update their KYC details, including PAN, address, and bank account details, to ensure eligibility for dividend payments. The disclosure was submitted to BSE Limited by Fredun Nariman Medhora, Managing Director and CFO of Fredun Pharmaceuticals Limited.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE194R01017/f5aceff8-f430-42fe-b252-360eb09860e9.pdf

Historical Stock Returns for Fredun Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.55%+2.02%+2.18%+50.57%+215.37%+516.34%

What key growth strategies will management outline for FY 2026-27 during the AGM?

Will the company announce any dividend payouts or changes in its dividend policy for the financial year ending March 31, 2026?

How does the company plan to address the transition of remaining physical shareholders to dematerialized form?

like18
dislike

Fredun Pharmaceuticals fixes June 23 record date for 7% final dividend

0 min read     Updated on 08 Jun 2026, 09:01 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Fredun Pharmaceuticals Limited announced June 23, 2026, as the record date for a 7% final dividend on ₹10 face value equity shares for FY26, pending shareholder approval at the Annual General Meeting.

powered bylight_fuzz_icon
42478286

*this image is generated using AI for illustrative purposes only.

Fredun Pharmaceuticals Limited has fixed June 23, 2026, as the record date for the payment of a final dividend for the financial year 2025-26. The company announced a dividend of 7% on equity shares with a face value of ₹10 each. This entitlement is subject to the approval of shareholders at the ensuing Annual General Meeting.

The record date of Tuesday, June 23, 2026, has been established to ascertain the members eligible for the payout. The dividend recommendation comes from the Board of Directors. If approved, the payment will be made within 30 days from the date of the Annual General Meeting, subject to the deduction of tax at source.

The intimation was submitted to BSE Limited pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was confirmed by Fredun Nariman Medhora, Managing Director of the company.

Dividend Details

Parameter Details
Dividend Type Final Dividend
Rate 7%
Face Value ₹10 each
Financial Year FY26
Record Date June 23, 2026

Historical Stock Returns for Fredun Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.55%+2.02%+2.18%+50.57%+215.37%+516.34%

How will this dividend payout impact Fredun Pharmaceuticals' cash flow and capital allocation plans for FY27?

What market reaction is anticipated regarding the company's stock price leading up to the June 2026 record date?

Could this dividend signal a shift in the company's strategy towards returning more value to shareholders in the coming years?

like19
dislike

More News on Fredun Pharmaceuticals

1 Year Returns:+215.37%